Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2025 07:48 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Report 2025: Industry Set to Double by 2030 Driven by Next-Gen Oncology Innovations, Reaching $16 Billion

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market by Payload Type (Auristatins, Calicheamicins, Maytansinoids), Indication (Breast Cancer, Hematological Cancer, Lung...
August 06, 2025 04:22 ET | Source: Research and Markets

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031" report has been added to ...
May 26, 2025 10:00 ET | Source: Exactitude Consultancy

Antibody Drug Conjugates (ADCs) Contract Manufacturing Market to Reach USD 7.5 Billion by 2034, Growing at 7.2% CAGR | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, May 26, 2025 (GLOBE NEWSWIRE) -- The global Antibody Drug Conjugates (ADCs) Contract Manufacturing Market is projected to grow from USD 3.8 billion in 2024 to...
May 20, 2025 04:16 ET | Source: Research and Markets

Global Antibody Drug Conjugates Market Report 2025-2035: North America Leads ADC Market Growth with Strong Infrastructure and Innovations

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market - 2025-2035: Focus on Product, Application, Target, Payload Type, Linker Type, Linker Technology, and Geography"...
April 25, 2025 04:23 ET | Source: Research and Markets

Antibody Drug Conjugates Market and Forecast to 2030: Trends, Developments and Shares by Type of ADC, Application, Region and Company

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 18, 2025 10:21 ET | Source: Research and Markets

Antibody-drug Conjugates Innovations Research Report 2025: $227 Billion in Deals Signal ADC Market Boom - Pfizer and Daiichi Sankyo Emerge as Leading Trial Sponsors

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Antibody-drug conjugates" has been added to ResearchAndMarkets.com's offering. ntibody-drug conjugates (ADCs) are redefining...
March 24, 2025 10:13 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Research 2024-2035: Currently, 47% of the ADCs are in Discovery / Preclinical Stages of Development

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target...
March 24, 2025 05:01 ET | Source: Research and Markets

Global Cancer Antibody Drug Conjugates Market Landscape 2024-2030 Featuring Biocytogen, Merck, AstraZeneca, Pfizer, Daiichi Sankyo, and ADC Therapeutics

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
January 15, 2025 11:03 ET | Source: Research and Markets

Antibody Drug Conjugates Market Outlook 2025-2035, with Forecasts for Payload Type, Linker Type, Target Antigen and Applications

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering.World revenue for the Antibody Drug Conjugates...
November 26, 2024 11:44 ET | Source: Research and Markets

Antibody Drug Conjugate Market Industry Trends and Forecasts to 2035, Featuring Profiles of Key Players ADC Therapeutics, Byondis, Daiichi Sankyo, Genentech, Gilead Sciences, ImmunoGen, RemeGen and More

Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target...